• HOME
  • ȸ»ç¼Ò°³
    • CEO Àλ縻
    • COMPANY OVERVIEW
    • HISTROY
    • ORGANIZATION
  • »ç¾÷¼Ò°³
    • PLATFORM Business(iCRO)
    • RWE & MEDICAL
    • STRATEGIC MARKETING
    • STRATEGIC BD
  • °í°´¼¾ÅÍ
    • ¿À½Ã´Â±æ
    • 1:1 »ó´ã
  • È«º¸¼¾ÅÍ
    • ¾ð·ÐÈ«º¸/±â»ç/FAQ
    • PORTFOLIO
·Î°í
  • HOME
  • ȸ»ç¼Ò°³
    • CEOÀλ縻
    • COMPANY OVERVIEW
    • HISTROY
    • ORGANIZATION
  • »ç¾÷¼Ò°³
    • PLATFORM Business(iCRO)
    • RWE & MEDICAL
    • STRATEGIC MARKETING
    • STRATEGIC BD
  • °í°´¼¾ÅÍ
    • ¿À½Ã´Â±æ
    • 1:1»ó´ã
  • È«º¸¼¾ÅÍ
    • ¾ð·ÐÈ«º¸ ¹× ±â»ç
    • ³»ºÎȰµ¿
    • THEWAY Blog
    • Æ÷ÅäÆ÷¸®¿À
    • ¿À½Ã´Â±æ









+ RWE & Medical +

´õ¿þÀÌÇコÄɾî RWE & MEDICAL »ç¾÷ºÎ´Â º¸°ÇÀÇ·á Big Data ºÐ¼®À» Ȱ¿ëÇÑ ´Ù¾çÇÑ Á¢±ÙÀ» Åä´ë·Î ¸ÂÃã½Ä RWE ¿¬±¸¿Í ÀÓ»ó½ÃÇè ¼öŹ ¾÷¹« Àü¹ÝÀÇ ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

 

+ CCS +

Clinic Chart review Study

The Way¸¸ÀÇ Â÷º°È­µÈ Ŭ¸®´Ð (°³¿øÀÇ) ÀÓ»ó ÇÁ·ÎÁ§Æ®

 

1Â÷ ÀÇ·á ±â°ü ´ë»ó ¼±Çà ¿¬±¸ ºÎÀç

°æÀïǰ°úÀÇ È®½ÇÇÑ brand differentiation & Ŭ¸®´Ð µ¥ÀÌÅÍ È®º¸

 

Ŭ¸®´Ð ´ë»ó Â÷Æ® ¸®ºä ¿¬±¸

ºê·£µåÀÇ key message¸¦ µÞ¹ÞħÇÒ ¼ö ÀÖ´Â ¸ÂÃãÇü ¿¬±¸ µðÀÚÀÎ

 

Ŭ¸®´Ð ´ë»ó ¿¬±¸¸¦ À§ÇÑ °ø¿ë IRB ½ÂÀÎ

ÀÓ»ó½ÃÇè ±ÔÁ¤°ú CP ±ÔÁ¤À» Áؼö

+ Outcomes Research +

Áúº´°ú ȯÀÚ Áß½ÉÀÇ ¼º°ú¿¬±¸·Î ¿Ï¼ºµÇ´Â ±Ù°Å Á᫐ ÀÇÇÐÀÇ ½ÇÇö

 

 

1. Burden of illness

Health economic burden (Cost study)
  • Direct medical cost
  • Direct non-medical cost
  • Indirect cost

2. Patient Reported Outcomes

Health Related Quality of Life( HRQOL)
  • Patient¡¯s satisfaction
  • Patient¡¯s preference
  • Patient¡¯s compliance(Treatment adherence)

3. Epidemiology

Natural history of disease
  • prevalence, incidence, disease
  • risk factor
  • Treatment pattern

+ ORBIT +

Outcome Research & Big data integrated Trend

º¸°Ç ÀÇ·á ºòµ¥ÀÌÅÍ ºÐ¼®°á°ú¸¦ ÅëÇÑ Korean data generation

 

ÀÇÇа迡¼­ °úÇÐÀû Áõ°ÅÀÇ °´°ü¼ºÀ» ¿ä±¸Çϱ⠽ÃÀÛ

±¹³» ±Ù°Å Áß½ÉÀÇÇÐ(Evidence based medicine)ÀÌ ¹ßÀü

´ëÇ¥¼ºÀ» °¡Áö´Â ±Ù°Å¸¦ ÅëÇØ °úÇÐÀû ´çÀ§¼º°ú ÀϹÝÈ­ È®º¸ °¡´É

 

½ÉÆò¿ø û±¸µ¥ÀÌÅÍ Áø·áÁ¤º¸ Áø·á³»¿ª(óġ, ½Ã¼ú, °Ë»ç, ó¹æÀü ¾à µî), Áø´Ü¸í, Áø·áºñ¿ë, ȯÀںδã±Ý, ȯÀÚ Àα¸ Ư¼º Á¤º¸, ¿ä¾ç±â°üÁ¤º¸ µî¿¡ °ü·ÃµÈ µ¥ÀÌÅ͸¦ Åä´ë·Î R&D ¹× ¸¶ÄÉÆÃ µîÀÇ È°¿ë

 

°Ç°­º¸Çè½É»çÆò°¡¿ø °³¹æ½Ã½ºÅÛ ÀÌ¿ëÇÔ

±¹¹Î°Ç°­¿µ¾çÁ¶»ç data, Çѱ¹ÀÇ·áÆÐ³Î data µî Ȱ¿ë °¡´É

´õ¿þÀÌ ºòµ¥ÀÌÅÍ ºÐ¼® Àü¹®°¡(Åë°èÇÐ ¹Ú»ç)¸¦ ÅëÇØ °³¹æµÈ º¸°ÇÀÇ·á

ºòµ¥ÀÌÅ͸¦ ÀÌ¿ëÇÏ¿© ³í¹®À» °ÔÀçÇÔÀ¸·Î½á ±Ù°Å Áß½ÉÀÇ ÀÇ¹Ì ÀÖ´Â °á°ú¸¦ Á¦°ø

ORBIT ¼Ò°³¿µ»ó ¹Ù·Î°¡±â
  
¾ð·ÐÈ«º¸ ¹× ±â»ç









  • (ÁÖ)´õ¿þÀÌÇコÄɾî
    ADDRESS : (¿ìÆí¹øÈ£ 06633) ¼­¿ï½Ã ¼­Ãʱ¸ ¼­ÃÊ´ë·Î 320 (Áö¹ø : ¼­Ãʵ¿ 1674-4¹øÁö) K-Tower 5Ãþ
    TEL : 02-3446-4744 | FAX : 02-3446-4743
    E-MAIL : theway@theway-hc.co.kr
    BUSINESS NO. : 220-87-84944